Guillain–Barre syndrome: demographics, clinical features, and outcome in a single tertiary care hospital, Oman

References

1. ↵
   1. Katirji B,
   2. Kaminski HJ,
   3. Preston DC,
   4. Ruff RL,
   5. Shapiro BE

   1. Gorson KC,
   2. Ropper AH

   (2002) Guillain-Barre syndrome (acute inflammatory demyelinating polyneuropathy) and related disorders. in Neuromuscular disorders in clinical practice, eds Katirji B, Kaminski HJ, Preston DC, Ruff RL, Shapiro BE (Butterworth Heinemann, Boston Mass), 544–566.
2. ↵
   1. Burns TM

   (2008) Guillain-Barré syndrome. Semin Neurol 28, 152–167.
3. ↵
   1. Kalita J,
   2. Misra UK,
   3. Goyal G,
   4. Das M

   (2014) Guillain-Barré syndrome: Subtypes and predictors of outcome from India. J Peripher Nerv Syst 19, 36–43.
4. ↵
   1. Van Doorn PA,
   2. Ruts L,
   3. Jacobs BC

   (2008) Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol 7, 939–950.
5. ↵
   1. Sejvar JJ,
   2. Baughman AL,
   3. Wise M,
   4. Morgan OW

   (2011) Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuroepidemiology 36, 123–133.
6. ↵
   1. Ansar V,
   2. Valadi N

   (2015) Guillain-Barré syndrome. Prim Care 42, 189–193.
7. ↵
   1. Dash S,
   2. Pai AR,
   3. Kamath U,
   4. Rao P

   (2015) Pathophysiology and diagnosis of Guillain-Barré syndrome - challenges and needs. Int J Neurosci 125, 235–240.
8. ↵
   1. Fujimura H

   (2013) The Guillain-Barré syndrome. Handb Clin Neurol 115, 383–402.
9. ↵
   1. Sivadon-Tardy V,
   2. Orlikowski D,
   3. Porcher R,
   4. Sharshar T,
   5. Durand MC,
   6. Enouf V,
   7. et al.

   (2009) Guillain-Barré syndrome and influenza virus infection. Clin Infect Dis 48, 48–56.
10. ↵
    1. Larsen JP,
    2. Kvåle G,
    3. Nyland H

    (1985) Epidemiology of the Guillain-Barré syndrome in the county of Hordaland, Western Norway. Acta Neurol Scand 71, 43–47.
11. ↵
    1. Zaheer M,
    2. Naeem M,
    3. Nasrullah M

    (2008) Seasonal variation and sex distribution in patients with Guillain-Barré syndrome. Pak J Neurol Sci 3, 6–8.
12. ↵
    1. Sharma G,
    2. Sood S,
    3. Sharma S

    (2013) Seasonal, age and gender variation of Guillain Barre Syndrome in a tertiary referral center in India. Neurosci Med 4, 23.
13. ↵
    1. Hughes RA,
    2. Swan AV,
    3. Raphaël JC,
    4. Annane D,
    5. van Koningsveld R,
    6. van Doorn PA

    (2007) Immunotherapy for Guillain-Barré syndrome: A systematic review. Brain 130, 2245–2257.
14. ↵
    1. Raphaël JC,
    2. Chevret S,
    3. Hughes RA,
    4. Annane D

    (2012) Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev 7, CD001798.
15. ↵
    1. Hughes RA,
    2. Wijdicks EF,
    3. Benson E,
    4. Cornblath DR,
    5. Hahn AF,
    6. Meythaler JM,
    7. et al.

    (2005) Supportive care for patients with Guillain-Barré syndrome. Arch Neurol 62, 1194–1198.
16. ↵
    1. Roodbol J,
    2. de Wit MC,
    3. Walgaard C,
    4. de Hoog M,
    5. Catsman-Berrevoets CE,
    6. Jacobs BC

    (2011) Recognizing Guillain-Barre syndrome in preschool children. Neurology 76, 807–810.
17. ↵
    1. McGrogan A,
    2. Madle GC,
    3. Seaman HE,
    4. de Vries CS

    (2009) The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review. Neuroepidemiology 32, 150–163.
18. ↵
    1. Arcila-Londono X,
    2. Lewis RA

    (2012) Guillain-Barré syndrome. Semin Neurol 32, 179–186.
19. ↵
    1. Asbury AK,
    2. Cornblath DR

    (1990) Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 27, S21–S24.
20. ↵
    1. Willison HJ,
    2. Jacobs BC,
    3. Van Doorn PA

    (2016) Guillain-Barré syndrome. Lancet 388, 717–727.
21. ↵
    1. Leonhard SE,
    2. Mandarakas MR,
    3. Gondim FAA,
    4. Bateman K,
    5. Ferreira MLB,
    6. Cornblath DR,
    7. et al.

    (2019) Diagnosis and management of Guillain-Barré syndrome in ten steps. Nat Rev Neurol 15, 671–683.
22. 1. Connolly BA,
    2. Jones GD,
    3. Curtis AA,
    4. Murphy PB,
    5. Douiri A,
    6. Hopkinson NS,
    7. et al.

    (2013) Clinical predictive value of manual muscle strength testing during critical illness: an observational cohort study. Crit Care 17, R229.
23. ↵
    1. Kleyweg RP,
    2. van der Meché FG,
    3. Schmitz PI

    (1991) Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve 14, 1103–1109.
24. ↵
    1. Van den Berg B,
    2. Walgaard C,
    3. Drenthen J,
    4. Fokke C,
    5. Jacobs BC,
    6. van Doorn PA

    (2014) Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nature Reviews Neurology 10, 469–482.
25. ↵
    1. Löffel NB,
    2. Rossi LN,
    3. Mumenthaler M,
    4. Lütschg J,
    5. Ludin HP

    (1977) The Landry-Gullian Barré syndrome. Complications, prognosis and natural history in 123 cases. J Neurol Sci 33, 71–79.
26. ↵
    1. Dhadke SV,
    2. Dhadke VN,
    3. Bangar SS,
    4. Korade MB

    (2013) Clinical profile of Guillain Barre syndrome. J Assoc Physicians India 61, 168–172.
27. ↵
    1. Bhargava A,
    2. Banakar BF,
    3. Pujar GS,
    4. Khichar S

    (2014) A study of Guillain-Barré syndrome with reference to cranial neuropathy and its prognostic implication. J Neurosci Rural Pract 5, S43–S47.
28. ↵
    1. Anandan C,
    2. Khuder SA,
    3. Koffman BM

    (2017) Prevalence of autonomic dysfunction in hospitalized patients with Guillain-Barré syndrome. Muscle Nerve 56, 331–333.
29. ↵
    1. Karimzadeh P,
    2. Bakhshande Bali MK,
    3. Nasehi MM,
    4. Taheri Otaghsara SM,
    5. Ghofrani M

    (2012) Atypical Findings of Guillain-Barré Syndrome in Children. Iran J Child Neurol 6, 17–22.
30. ↵
    1. Ropper AH

    (1992) The Guillain– Barré syndrome. N Engl J Med 326, 1130–1136.
31. ↵
    1. Lawn ND,
    2. Fletcher DD,
    3. Henderson RD,
    4. Wolter TD,
    5. Wijdicks EF

    (2001) Anticipating mechanical entilation in Guillain-Barré syndrome. Arch Neurol 58, 893–898.
32. ↵
    1. Van Koningsveld R,
    2. Rico R,
    3. Gerstenbluth I,
    4. Schmitz PI,
    5. Ang CW,
    6. Merkies IS,
    7. et al.

    (2001) Gastroenteritis-associated Guillain-Barré syndrome on the Caribbean Island Curaçao. Neurology 56, 1467–1472.
33. ↵
    1. Nachamkin I,
    2. Barbosa PA,
    3. Ung H,
    4. Lobato C,
    5. Rivera AG,
    6. Rodriguez P,
    7. et al.

    (2007) Patterns of Guillain-Barre syndrome in children: Results from a Mexican population. Neurology 69, 1665–1671.
34. ↵
    1. Gupta D,
    2. Nair M,
    3. Baheti NN,
    4. Sarma PS,
    5. Kuruvilla A

    (2008) Diplomate-American Board. Electrodiagnostic and clinical aspects of Guillain-Barré syndrome: an analysis of 142 cases. J Clin Neuromuscul Dis 10, 42–51.
35. ↵
    1. Sharma A,
    2. Lal V,
    3. Modi M,
    4. Vaishnavi C,
    5. Prabhakar S

    (2011) Campylobacter jejuni infection in Guillain-Barré syndrome: A prospective case control study in a tertiary care hospital. Neurol India 59, 717–721.
36. ↵
    1. Islam Z,
    2. Jacobs BC,
    3. van Belkum A,
    4. Mohammad QD,
    5. Islam MB,
    6. Herbrink P,
    7. et al.

    (2010) Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh. Neurology 74, 581–587.
37. ↵
    1. Haghighi AB,
    2. Banihashemi MA,
    3. Zamiri N,
    4. Sabayan B,
    5. Heydari ST,
    6. Safari A,
    7. et al.

    (2012) Seasonal variation of Guillain-Barré syndrome admission in a large tertiary referral center in Southern Iran: A 10 year analysis. Acta Neurol Taiwan 21, 60–63.
38. ↵
    1. Sriganesh K,
    2. Netto A,
    3. Kulkarni GB,
    4. Taly AB,
    5. Umamaheswara Rao GS

    (2013) Seasonal variation in the clinical recovery of patients with Guillain Barré syndrome requiring mechanical ventilation. Neurol India 61, 349–354.
39. ↵
    1. Winer JB,
    2. Hughes RAC,
    3. Greenwood RJ,
    4. Perkin GD,
    5. Healy MJR

    (1985) Prognosis in Guillain-Barré syndrome. Lancet 1, 1202–1203.
40. 1. Alshekhlee A,
    2. Hussain Z,
    3. Sultan B,
    4. Katirji B

    (2008) Guillain-Barré syndrome: incidence and mortality rates in US hospitals. Neurology 70, 1608–1613.
41. ↵
    1. Van den Berg B,
    2. Bunschoten C,
    3. van Doorn PA,
    4. Jacobs BC

    (2013) Mortality in Guillain-Barre syndrome. Neurology 80, 1650–1654.
42. ↵
    1. Verboon C,
    2. Doets AY,
    3. Galassi G,
    4. Davidson A,
    5. Waheed W,
    6. Yann Péréon Y,
    7. et al.

    (2019) on behalf of the IGOS Consortium. Current treatment practice of Guillain-Barré syndrome. Neurology 93, e59–e76.